| |
| | Treatment with Serotonin-Norepinephrine Reuptake Inhibitor Reduces Rate of Relapse in Panic Disorder: Presented at CPA (Site not responding. Last check: 2007-10-31) |
 | | Panic disorder is a chronic illness often associated with comorbid psychiatric conditions, including depression and social anxiety disorder. |
 | | Short-term treatment with the serotonin norepinephrine reuptake inhibitor (SNRI) venlafaxine XR has been shown to be effective, said investigator James Ferguson MD, Clinical Professor of Psychiatry, University of Utah School of Medicine, Salt Lake City, Utah, United States. |
 | | Ferguson and colleagues conducted a prospective, randomised, double-blind, placebo-controlled study to investigate the ability of venlafaxine XR to prevent relapse in patients who had experienced improvements in PD symptoms with short-term therapy with venlafaxine XR. |
| www.pslgroup.com /dg/254CEE.htm (466 words) |
|